Loss of Th22 Cells Is Associated With Increased Immune Activation and IDO-1 Activity in HIV-1 Infection-Reference-Cited by-同舟云学术

Loss of Th22 Cells Is Associated With Increased Immune Activation and IDO-1 Activity in HIV-1 Infection

Published:2014-11-01 Issue:3 Volume:67 Page:227-235
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Page Emma E.,Greathead Louise,Metcalf Rebecca,Clark Sally-Ann,Hart Melanie,Fuchs Dietmar,Pantelidis Panagiotis,Gotch Frances,Pozniak Anton,Nelson Mark,Boasso Adriano,Gazzard Brian,Kelleher Peter

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference34 articles.

1. Pathogenic mechanisms of HIV disease.;Moir;Annu Rev Pathol,2011

2. Microbial translocation in HIV infection: causes, consequences and treatment opportunities.;Sandler;Nat Rev Microbiol,2012

3. Mucosal immunity in human and simian immunodeficiency lentivirus infections.;Brenchley;Mucosal Immunol,2013

4. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.;Sonnenberg;Nat Immunol,2011

5. . Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria.;Sonnerberg;Science,2012

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunometabolites in viral infections: Action mechanism and function;Journal of Medical Virology;2024-07

2. Indoleamine 2,3-dioxygenase (IDO1) – Can dendritic cells and monocytes expressing this moonlight enzyme change the phase of Parkinson’s Disease?;International Immunopharmacology;2024-05

3. Effect of high dose vitamin D3 on the HIV-1 reservoir: A pilot randomised controlled trial;Journal of Virus Eradication;2023-09

4. Immune Responses in Lung Granulomas during Mtb/HIV Co-Infection: Implications for Pathogenesis and Therapy;Pathogens;2023-09-01

5. Decreased frequency of Th22 cells and IL-22 cytokine in kidney transplant patients with active cytomegalovirus infection;BMC Immunology;2023-07-04